organoids

A new discussion in drug discovery circles argues that reproducibility standards need to be rethought for advanced 3D cell models, such as organoids and spheroids. Because these systems are more complex and variable than traditional 2D cultures, conventional reproducibility criteria may not apply, prompting calls for updated guidelines on how such experiments are validated and reported across laboratories.